Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.

NCT02063139 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Persistent Asthma

Interventions

DRUG: Flutiform 50/5 ug (2 puffs bid) pMDI
DRUG: Fluticasone 50 ug (2puffs bid) pMDI
DRUG: Beclometasone Autohaler 50 ug (2 puffs bid)

Sponsor

Mundipharma Research Limited